Clinica Doctor Balcangiu-Stroescu

Facial rejuvenation with laser: what it is, how it works, and what to expect

Facial rejuvenation with laser: what it is, how it works, and what to expect
Useful information
March 29, 2026Gabriel-Cosmin Balcangiu-Stroescu

Facial laser rejuvenation is a modern, non-invasive or minimally invasive procedure used to improve skin appearance, reduce wrinkles, and stimulate collagen production.

It is one of the most effective methods for achieving smoother, brighter, and more youthful-looking skin without surgical intervention.

What is facial laser rejuvenation

Facial laser rejuvenation involves using laser energy to stimulate skin regeneration.

👉 The laser works by:

  • stimulating collagen production
  • improving skin texture
  • reducing fine wrinkles
  • evening out skin tone

What it is recommended for

The procedure is effective for:

  • fine wrinkles
  • enlarged pores
  • improvement of skin laxity
  • pigmentation spots
  • post-acne scars
  • uneven texture

How it works

The laser creates controlled micro-injuries to the skin, which triggers:

  • activation of regeneration processes
  • production of collagen and elastin
  • restoration of skin structure

👉 Results appear progressively as the skin regenerates.

How the procedure is performed

It generally takes between 20 and 40 minutes.

  1. Skin cleansing
  2. Application of anesthetic cream (sometimes)
  3. Application of laser
  4. Application of soothing product

👉 The procedure is well tolerated by most patients.

When do results appear

  • skin may be slightly red immediately after the procedure
  • visible improvements in 1–2 weeks
  • optimal results after multiple sessions

👉 Collagen continues to be produced in the following months.

Instructions before the procedure

For optimal results:

2 weeks before:

  • avoid sun exposure
  • avoid tanning

A few days before:

  • avoid retinol and exfoliating acids
  • avoid aggressive procedures

Instructions after laser rejuvenation

For proper recovery:

In the first few days:

  • apply soothing cream
  • avoid sun
  • use SPF 50

In the first 5–7 days:

  • avoid makeup (if skin is sensitive)
  • avoid irritating products
  • avoid sauna and excessive heat

Reactions after the procedure

It is normal to experience:

  • redness
  • slight burning sensation
  • mild flaking
  • sensitivity

👉 These are temporary.

Who is NOT a suitable candidate

The procedure is not recommended:

  • during pregnancy
  • in active skin infections
  • on recently tanned skin
  • in certain dermatological conditions

💡 Advantages of laser rejuvenation

  • stimulates natural collagen
  • improves skin texture
  • progressive and natural results
  • results without surgical intervention

❓ Frequently asked questions (FAQ)

Is the procedure painful?

Discomfort is mild and manageable.

How many sessions are needed?

Usually 2–4 sessions.

How long is the recovery?

From a few days to a week, depending on the laser type.

Are results permanent?

Not completely, but they are long-lasting with maintenance.

When to see a doctor

A consultation is recommended if:

  • you have skin texture problems
  • you have spots or fine wrinkles
  • you want non-invasive rejuvenation

📞 Schedule your evaluation

For a personalized plan and selection of the appropriate laser type:

👉 Schedule a consultation for recommendations tailored to your needs.

Also Read

Related Articles

A single injection for cholesterol — from dreams to first human results
Useful information

A single injection for cholesterol — from dreams to first human results

A Phase 1 trial published in the New England Journal of Medicine (November 2025) brings remarkable results: a single infusion of CTX310, a CRISPR-Cas9 therapy developed by Cleveland Clinic and CRISPR Therapeutics, reduced LDL cholesterol by up to 49% and triglycerides by up to 55% in patients with refractory dyslipidemia — without serious adverse events. The mechanism is unique: instead of blocking a protein or interfering with its mRNA, CTX310 permanently edits the ANGPTL3 gene in hepatic cells, mimicking a natural mutation associated with reduced cardiovascular risk throughout life. The therapy is currently in Phase 1b clinical stage, with updates expected in the second half of 2026. It is not approved and does not replace current treatments. Read the full article for clinical context, comparison with statins and PCSK9 inhibitors, and what these data mean for patients. Medical Disclaimer This article presents results from a Phase 1 clinical trial in an early-stage research phase. The therapy described is not approved and is not available as standard treatment. The information is for educational purposes only. Consult your physician for any medical decision.

June 1, 2026Andra-Elena Balcangiu-Stroescu

Ready to schedule?

Book an appointment online or call us directly.

+40 747 777 107